• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在免疫缺陷小鼠中建立非小细胞肺癌患者来源的异种移植模型]

[Establishment of patient-derived xenotransplantation models for non-small cell lung cancer in immune deficient mice].

作者信息

Hu Ye-Rong, Ren Hong, Liu Zhe-Liang, Yu Feng-Lei, Liu Wen-Liang, Zhou Xin-Min

机构信息

Department of Cardiothoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China.

出版信息

Ai Zheng. 2009 Aug;28(8):890-3. doi: 10.5732/cjc.009.10019.

DOI:10.5732/cjc.009.10019
PMID:19664340
Abstract

BACKGROUND AND OBJECTIVE

Targeted therapies have become a valuable therapeutic option for cancer. Establishment of different animal tumor models has become necessary. This study was to establish xenotransplantation models for patient-derived non-small cell lung cancer (NSCLC) in immune deficient mice.

METHODS

Immune deficient mice, BALB/C-nu, NOD/scid and SCID, 16 in each strain, were used. Sixteen tumor specimens were obtained from patients with NSCLC. Each specimen was subcutaneously transplanted into one mouse from each of the three strains. The tumor formation rate, time to tumor engraftment, tumor volume doubling time were recorded and compared among the three strains of mice. Histology of xenograft tumors was examined.

RESULTS

The total tumor formation rate was 75% (12/16). The tumor formation rate was the highest in SCID mice (56.25%). Only four tumors were engrafted in SCID mice, and two in BALB/C-nu mice. The tumor formation rate, time to tumor engraftment, and tumor volume doubling time were not significantly different among the three strains of mice. The incidence of tumor size over 1cm in the upper flanks of the mice (56.25%) was significantly higher than that in the lower flanks (25%) (P=0.037). Haematoxylin Eosin staining revealed a high degree of histological similarity between all xenograft and the parental tumors.

CONCLUSIONS

We have established xenotransplantation models for patient-derived NSCLC with a success rate of 75% in BALB/C-nu and SCID mice. The xenograft tumors have the same histological features to those of their parental tumors.

摘要

背景与目的

靶向治疗已成为癌症治疗的重要选择。建立不同的动物肿瘤模型变得十分必要。本研究旨在建立免疫缺陷小鼠的人源非小细胞肺癌(NSCLC)异种移植模型。

方法

使用免疫缺陷小鼠,BALB/C-nu、NOD/scid和SCID各16只。从NSCLC患者获取16个肿瘤标本。每个标本分别皮下移植到三种品系的各一只小鼠体内。记录并比较三种品系小鼠的肿瘤形成率、肿瘤接种时间、肿瘤体积倍增时间。检查异种移植肿瘤的组织学情况。

结果

总肿瘤形成率为75%(12/16)。SCID小鼠的肿瘤形成率最高(56.25%)。SCID小鼠仅接种了4个肿瘤,BALB/C-nu小鼠接种了2个。三种品系小鼠的肿瘤形成率、肿瘤接种时间和肿瘤体积倍增时间无显著差异。小鼠上腹部肿瘤大小超过1cm的发生率(56.25%)显著高于下腹部(25%)(P=0.037)。苏木精-伊红染色显示所有异种移植肿瘤与其亲本肿瘤在组织学上高度相似。

结论

我们成功建立了人源NSCLC异种移植模型,在BALB/C-nu和SCID小鼠中的成功率为75%。异种移植肿瘤与其亲本肿瘤具有相同的组织学特征。

相似文献

1
[Establishment of patient-derived xenotransplantation models for non-small cell lung cancer in immune deficient mice].[在免疫缺陷小鼠中建立非小细胞肺癌患者来源的异种移植模型]
Ai Zheng. 2009 Aug;28(8):890-3. doi: 10.5732/cjc.009.10019.
2
[Establishment and its biological characteristics of patient-derived lung cancer xenograft models].[患者来源的肺癌异种移植模型的建立及其生物学特性]
Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):568-74. doi: 10.3779/j.issn.1009-3419.2010.06.020.
3
[Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].[小细胞肺癌患者来源的异种移植动物模型及耐药模型的建立]
Zhongguo Fei Ai Za Zhi. 2019 Jan 20;22(1):6-14. doi: 10.3779/j.issn.1009-3419.2019.01.03.
4
Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.高危型子宫内膜癌患者来源肿瘤异种移植模型的建立。
Int J Gynecol Cancer. 2018 Nov;28(9):1812-1820. doi: 10.1097/IGC.0000000000001365.
5
Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.非小细胞肺癌中白细胞介素6产生与肿瘤增殖之间的相关性
Cancer Immunol Immunother. 2004 Sep;53(9):786-92. doi: 10.1007/s00262-004-0533-9. Epub 2004 Jun 4.
6
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.非小细胞肺癌患者来源异种移植瘤的分子异质性与其原发肿瘤密切相关。
Int J Cancer. 2017 Feb 1;140(3):662-673. doi: 10.1002/ijc.30472. Epub 2016 Nov 7.
7
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.与免疫缺陷小鼠中患者来源的非小细胞肺癌异种移植物植入相关的肿瘤特征。
Cancer. 2019 Nov 1;125(21):3738-3748. doi: 10.1002/cncr.32366. Epub 2019 Jul 9.
8
Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.TUG1和LCAL6长链非编码RNA的siRNA沉默对非小细胞肺癌患者来源异种移植瘤的影响
Anticancer Res. 2018 Jan;38(1):179-186. doi: 10.21873/anticanres.12206.
9
The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.形成原发性肿瘤异种移植物的能力可预测早期非小细胞肺癌疾病复发的风险增加。
Clin Cancer Res. 2011 Jan 1;17(1):134-41. doi: 10.1158/1078-0432.CCR-10-2224. Epub 2010 Nov 16.
10
Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.通过改进分析前步骤建立非小细胞肺癌患者来源肿瘤异种移植的广泛模型。
Cancer Med. 2015 Feb;4(2):201-11. doi: 10.1002/cam4.357. Epub 2014 Dec 3.